Cell-Specific Genetic Mapping Links Neuronal and Immune Pathways to Neuropsychiatric Risk

The clinical management of neuropsychiatric disorders remains challenged by a highly polygenic architecture, a genetic structure where thousands of small-effect variants collectively influence disease risk [1, 2, 3]. While genome-wide association studies have identified numerous risk loci, such as the 102 independent variants associated with major depression [1] and 102 risk genes identified in autism spectrum disorder [4], the specific cellular mechanisms driving pathology often remain elusive [5, 6]. Recent evidence suggests these conditions involve more than primary neuronal defects, specifically implicating neuroinflammation and dysregulation of the brain extracellular matrix, which is the scaffold of molecules providing structural and biochemical support to cells [7, 8]. Furthermore, the overlap between central nervous system symptoms and peripheral immune markers, including shared genetic pathways between blood cell indices and schizophrenia [9], suggests a systemic component to these traditionally brain-centered illnesses [2]. A new study [6] now integrates single-cell expression quantitative trait locus data (a method to identify genetic variants that influence the expression levels of genes in specific cell types) with large-scale genetic associations to map risk to specific cell types across six major disorders.